Synergistic effects of PI3K/Akt on abrogation of cytokine-dependency induced by oncogenic Raf

Advances in Enzyme Regulation

Volumn 41, Issue 1, 2001, Pages 289-323

  McCubrey, James A ^a,b   Steelman, Linda S ^a   Blalock, William L ^a   Lee, John T ^a   Moye, Phillip W ^a   Chang, Fumin ^a   Pearce, Marianne ^a   Shelton, John G ^a   White, Martyn K ^b   Franklin, Richard A ^a,b   Pohnert, Steven C ^b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GREEN FLUORESCENT PROTEIN; GROWTH PROMOTOR; HYBRID PROTEIN; INTERLEUKIN 3; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; PHOTOPROTEIN; PROTEIN BCL 2; PROTO ONCOGENE PROTEIN AKT; PROTO ONCOGENE PROTEINS; PROTO ONCOGENE PROTEINS C BCL 2; PROTO ONCOGENE PROTEINS C RAF; PROTO-ONCOGENE PROTEIN AKT; RAF PROTEIN; RNA; THYMIDINE;

ANIMAL; ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; BIOLOGICAL MODEL; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME ANALYSIS; HEMATOPOIETIC CELL; HUMAN; LEUKEMIA; MODEL; MOUSE; NONHUMAN; ONCOGENE; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RETROVIRUS; SIGNAL TRANSDUCTION; TIME; WESTERN BLOTTING;

ANIMALIA; MURINAE; RETRO VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0034987505     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2571(00)00021-2     Document Type: Article

References (113)

1. Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: Sites for intervention with anti-neoplastic drugs
2. Abnormal activation of cytokine gene expression by intracisternal type A particle transposition: Effects of mutations which result in autocrine growth factor stimulation and malignant transformation
3. Regulation of interleukin 3 expression in normal and autocrine transformed hematopoietic cells
4. Differential effects of retroviral long terminal repeats on interleukin 3 gene expression and autocrine transformation
5. Differential abilities of activated Raf oncoproteins to abrogate cytokine-dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells
6. Autocrine transformation of human hematopoietic cells after transfection with an activated granulocyte/macrophage colony-stimulating factor gene
7. Regulation of the interleukin-3 (IL-3) receptor by IL-3 in the fetal liver-derived FL5.12 cell line
8. Oncogenic effects of overexpression of the interleukin-3 receptor on hematopoietic cells
9. Growth factor-dependent hemopoietic precursor cell lines
10. Enrichment of hematopoietic precursor cells and cloning of multipotential B lymphocyte precursors
11. Abrogation of facto-dependence in 2 IL-3 dependent cell lines can occur by two distinct mechanisms
12. Retroviral infection can abrogate the factor-dependency of hematopoietic cells by autocrine and non-autocrine mechanisms depending on the presence of a functional viral oncogene
13. Autocrine growth factor secretion after transformation of human cytokine-dependent cells by viral and cellular oncogenes
14. Differential effects of viral and cellular oncogenes on the growth factor-dependency of hematopoietic cells
15. A conditionally-active form of MEK1 results in autocrine transformation of human and mouse hematopoietic cells
16. Effects of a conditional MEK1 oncogene on the cytokine-dependency and prevention of apoptosis in a lymphoid cell line
17. Differential abilities of the Raf family of protein kinases to abrogate cytokine-dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism
18. Serine/threonine phosphorylation in cytokine signal transduction
19. Diptheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemias
20. Effects of deregulated Raf and MEK1 expression on the cytokine-dependency of hematopoietic cells
21. Combined effects of aberrant MEK1 activity and BCL2 overexpression on relieving the cytokine-dependency of human and murine hematopoietic cells
22. Synergy between Raf and BCL2 in abrogating the cytokine -dependency of hematopoietic cells
23. Raf signal transduction cascade as a target for chemotherapeutic intervention in growth factor-dependent tumors
24. Kinases: Positive and negative regulators of apoptosis
25. Raf induces CIPp21 expression in hematopoietic cells
26. Signaling through the hematopoietic cytokine receptors
27. Critical cytoplasmic domains of the common beta subunit responsible for differentiation
28. Suppression of apoptotic death in hematopoietic cells by signaling through the IL-3/GM-CSF receptors
29. Apoptosis meets signal transduction: Elimination of a bad influence
30. Bcl-2 associates with the ras-related protein R-ras p23
31. Apoptosis regulation by interaction of Bcl-2 and Raf-1 kinase
32. Bcl-2 targets the protein kinase Raf-1 to mitochondria
33. L and Bcl-2 displaces Bax and promotes cell death
34. L
35. Beta interferon and oncostatin M activate Raf-1 and mitogen -activated protein kinase through a JAK1-dependent pathway
36. Interferon gamma activation of Raf-1 is Jak1-dependent and p21ras-independent
37. Mechanisms regulating Raf-1 activity in signal tranduction pathways
38. Drosophila melanogaster homologs of the raf oncogene
39. Raf oncogenes in carcinogenesis
40. Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells
41. Post-natal lethality and neurological and gastrointestinal defects in mice with targeted disruption of the A-Raf protein kinase
42. Endothelial apoptosis in Braf-deficient mice
43. C-raf-1 protein kinase is essential for mouse development
44. Definition of the human raf amino-terminal regulatory region by deletion mutagenesis
45. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase
46. Conditionally oncogenic forms of the A-raf and B-raf protein kinases display different biological and biochemical properties in NIH 3T3 cells
47. Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1
48. Critical tyrosine residues regulate the enzymatic and biological activity of raf-1 kinase
49. Ras recruits raf-1 to the plasma membrane for activation by tyrosine phosphorylation
50. Transformation of mammalian cells by constitutively active MAP kinase kinase
51. Constitutively active mutants of MAP kinase kinase (MEK 1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts
52. Transcriptional regulation by MAP kinases
53. AKT: ER a conditional Akt gene which transforms fibroblast NIH-3T3 cells
54. Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation
55. Requirement for phosphatidylinositol-3-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor
56. Activation of phosphatidlyinositol 3-kinase is necessary for differentiation of FDC-P1 cells following stimulation of type III receptor tyrosine kinases
57. Phosphoinositide 3-kinases: A conserved family of signal transducers
58. The modular phosphorylation and activation of p70S6K
59. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase
60. Interleukin 3-dependent survival by the Akt protein kinase
61. Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/Akt: Involvement of MEK upstream of Bad phosphorylation
62. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
63. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
64. Phosphatidylinositol 3-OH kinase activity is not required for activation of mitogen-activated protein kinase by cytokines
65. Regulation of Bad phosphorylation and association with Bcl-xL by the MAPK/ERK kinase
66. Role of phosphatidylinositol 3-OH-kinase activity in the inhibition of apoptosis in haemopoietic cells: Phosphatidylinositol 3-OH-kinase inhibitors reveal a difference in signalling between interleukin-3 and granulocyte-macrophage colony stimulating factor
67. Dissociation of apoptosis from proliferation, protein kinase B activation, and Bad phosphorylation in interleukin-3-mediated phosphoinositide 3-kinase signaling
68. Role of phosphoinositide 3-kinase in activation of ras and mitogen-activated protein kinase by epidermal growth factor
69. A phosphatidylinositol 3-kinase-dependent pathway that differentially regulates c-Raf and A-Raf
70. AFX-like forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27Kipl
71. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt
72. Phosphorylation and regulation of Raf by Akt (Protein Kinase B)
73. Role of raf-1 protein kinase in IL-3 and GM-CSF mediated signal transduction
74. v-raf suppresses apoptosis and promotes growth of interleukin-3-dependent myeloid cells
75. Effect of Abelson murine leukemia virus on granulocytic differentiation and interleukin-3 dependence of a murine progenitor cell line
76. Viral models for understanding chronic myelogenous leukemia
77. Malignant transformation of a growth factor-dependent myeloid cell line by Abelson virus without evidence of an autocrine mechanism
78. Neoplastic transformation of mast cells by Abelson MuLV: Abrogation of IL-3 dependence by a nonautocrine mechanism
79. Abelson virus abrogation of interleukin-3 dependence in a lymphoid cell line
80. Reversible dependence on growth factor interleukin-3 in myeloid cells expressing temperature sensitive v-abl oncogene
81. Signal transduction through the EGF receptor transfected into IL-3-dependent hematopoietic cells
82. Growth promoting effects of insulin-like growth factor-1 on hematopoietic cells: Overexpression of introduced IGF-1 receptor abrogates IL-3-dependency of murine factor dependent cells by a ligand-dependent mechanism
83. Transformation of FDC-P1 cells to IL-3 independence by a murine retrovirus containing v-erb-B
84. Transformation of early erythroid precursor cells (BFU-E) by a recombinant murine retrovirus containing v-erb-B
85. The v-fms oncogene induces factor-independent growth and transformation of the interleukin-3-dependent myeloid cell line FDC-P1
86. Induction of macrophage colony-stimulating factor-dependent growth and differentiation after introduction of the murine c-fms gene into FDC-P1 cells
87. Abrogation of IL-3 dependent growth requires a functional v-src gene product: Evidence for an autocrine growth cycle
88. Nature and specificity of lymphokine independence induced by a selectable retroviral vector expressing v-src
89. A retrovirus encoding the v-fps protein-tyrosine kinase induces factor-independent growth and tumorigenicity in FDC-P1 cells
90. Acquisition of interleukin-3 independence in FDC-P2 cells after transfection with the activated c-H-ras gene using a bovine papillomavirus-based plasmid vector
91. Transformation of an interleukin-3 dependent hematopoietic cell line by the chronic myelogenous leukemia-specific p210 BCR-ABL protein
92. Bcr-abl oncogene renders myeloid cell line factor independent: Potential autocrine mechanism in chronic myeloid leukemia
93. Biological consequences of p60v-abl protein tyrosine kinase activity in a primitive, multipotent haemopoietic cell line
94. A temperature sensitive p210 BCR-ABL mutant defines the primary consequences of BCR-ABL tyrosine kinase expression in growth factor dependent cells
95. Transfection of the bcr/abl oncogene into factor-dependent cells by electroporation: Acquisition of autonomous proliferation
96. Expression of the chronic myelogenous leukemia-associated p20bcr/abl oncoprotein in a murine IL-3 dependent myeloid cell line
97. Clonal evolution in a myeloid cell line transformed to interleukin-3 independent growth by retroviral transduction and expression of p210bcr/abl
98. p210BCR/ABL, p190/BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cells
99. Oligomerization of the abl tyrosine kinase by the Ets protein TEL in human leukemia
100. ATel-Jak2 fusion protein with constitutive kinase activity in human leukemia
101. Jak-Stat signaling induced by the v-abl oncogene
102. p210 and p190 (BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific Stat family members
103. Constitutive activation of JAK1 in Src-transformed cells
104. The role of MAP kinase in interleukin-3 stimulation of proliferation
105. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines
106. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras
107. Improved retroviral vectors for gene transfer and expression
108. Advanced mammalian gene transfer: High titer retroviral vectors with multiple drug selection markers and a complementary, helper-free packaging cell line
109. Autocrine secretion of GM-CSF in acute myeloblastic leukemia
110. Expression of bcr-abl abrogates factor-dependent growth of human hematopoietic M07E cells by an autocrine mechanism
111. Effects of phorbol esters on an interleukin-3-dependent cell line
112. Interleukin-3 and phorbol esters induce different patterns of immediate-early gene expression in an interleukin-3-dependent cell line
113. Differential effect of phorbol esters and IL-3 on protein kinase C isoform content and kinase activity in the FDC-P1 cell line